Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Arriaga · SciRah

Researcher profile · Semantic Scholar

Y. Arriaga

Share profile

Y. Arriaga — researcher profile on SciRah

h-index: 19
Works: 93
Citations: 1,462

Most-cited papers

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients
K. Courtney, Yuanqing Ma, Alberto de Léon, A. Christie +24 more
2019Clinical Cancer Research146 citations Open access
Semantic Scholar
Artificial intelligence in oncology: Path to implementation
Isaac S. Chua, Michal Gaziel-Yablowitz, Z. Korach, K. Kehl +5 more
2021Cancer Medicine145 citations Open access
Semantic Scholar
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
E. Van Cutsem, E. Martinelli, S. Cascinu, A. Sobrero +19 more
2018The Oncologist140 citations Open access
Semantic Scholar
Contemporary use of perioperative cisplatin‐based chemotherapy in patients with muscle‐invasive bladder cancer
G. Raj, Saumil S Karavadia, B. Schlomer, Y. Arriaga +3 more
2011Cancer140 citations Open access
Semantic Scholar
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
V. Willis, K. J. Thomas Craig, Y. Jabbarpour, Elisabeth L. Scheufele +4 more
2021JMIR Medical Informatics100 citations Open access
Semantic Scholar
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
David E. Gerber, M. Beg, F. Fattah, A. Frankel +16 more
2018British Journal of Cancer89 citations Open access
Semantic Scholar
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
A. Diab, H. Gogas, S. Sandhu, G. Long +22 more
2023Journal of Clinical Oncology79 citations Open access
Semantic Scholar
Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Y. Lotan, A. Bagrodia, N. Passoni, V. Rachakonda +7 more
2013European Urology72 citations
Semantic Scholar
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients
Masato Kobayashi, Jin-Sung Chung, M. Beg, Y. Arriaga +12 more
2018Clinical Cancer Research53 citations Open access
Semantic Scholar
Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery
S. Lucas, R. Svatek, Guadencio Olgin, Y. Arriaga +3 more
2008BJU International44 citations
Semantic Scholar
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
O. Mohamad, Alberto Diaz de Leon, S. Schroeder, Andrew J. Leiker +16 more
2018Oncoimmunology38 citations Open access
Semantic Scholar
Improved Survival Outcomes for Kidney Cancer Patients with Brain Metastases
I. Bowman, Alisha H. Bent, Tri Le, A. Christie +13 more
2018Clinical Genitourinary Cancer28 citations Open access
Semantic Scholar
Comparison of an oncology clinical decision-support system’s recommendations with actual treatment decisions
S. Suwanvecho, H. Suwanrusme, T. Jirakulaporn, S. Issarachai +16 more
2021J. Am. Medical Informatics Assoc.25 citations Open access
Semantic Scholar
Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
L. Krabbe, M. E. Westerman, V. Margulis, G. Raj +4 more
2014The Canadian journal of urology25 citations
Semantic Scholar
Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.
S. Woldu, A. Aydin, Ashwin Rao, R. Hutchinson +12 more
2018Urology24 citations
Semantic Scholar
Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities
K. J. Thomas Craig, Nicole Fusco, K. Lindsley, J. Snowdon +3 more
2020Cardiovascular Digital Health Journal23 citations Open access
Semantic Scholar
FIERCE-21: Phase 1b/2 study of docetaxel + b-701, a selective inhibitor of FGFR3, in relapsed or refractory (R/R) metastatic urothelial carcinoma (mUCC).
J. Bellmunt, J. Picus, M. Kohli, Y. Arriaga +4 more
201823 citations
Semantic Scholar
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
R. Hannan, O. Mohamad, Alberto de Léon, Subrata Manna +23 more
2021Clinical Cancer Research22 citations Open access
Semantic Scholar
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
Ali A. Mokdad, Hao Zhu, M. Beg, Y. Arriaga +3 more
2019Targeted oncology22 citations
Semantic Scholar
Adverse effects of bevacizumab and their management in solid tumors.
Y. Arriaga, C. Becerra
2006Supportive Cancer Therapy19 citations
Semantic Scholar
Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes
S. Woldu, J. A. Moore, Ci Bo, Y. Freifeld +12 more
2018European Urology Oncology16 citations Open access
Semantic Scholar
Variations in breast cancer surgical treatment and timing: determinants and disparities
I. Dankwa-Mullan, Judy George, M. C. Roebuck, J. Tkacz +3 more
2021Breast Cancer Research and Treatment14 citations Open access
Semantic Scholar
Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
R. Hannan, M. Dohopolski, Laurentiu M. Pop, S. Mannala +12 more
2022Biomedicines13 citations Open access
Semantic Scholar
Phase II trial of high-dose interleukin-2 (IL-2) and stereotactic radiation therapy (SABR) for metastatic clear cell renal cell carcinoma (ccRCC): Interim analysis.
R. Hannan, D. Ishihara, K. Louder, C. Ahn +5 more
201613 citations
Semantic Scholar
Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension.
S. R. Shah, S. M. Gressett Ussery, J. Dowell, E. Marley +3 more
2013Annals of Oncology13 citations Open access
Semantic Scholar
Unintended Consequences of Systemic and Ablative Oncologic Therapy in the Abdomen and Pelvis.
J. Birch, Gaurav Khatri, L. Watumull, Y. Arriaga +1 more
2018Radiographics12 citations
Semantic Scholar
Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase IIIb CONSIGN trial.
E. Van Cutsem, F. Ciardiello, M. Ychou, J. Seitz +10 more
201612 citations
Semantic Scholar
Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival
Peng-Ju Chen, Tian-le Li, T. Sun, V. Willis +6 more
2020Diseases of the Colon & Rectum11 citations
Semantic Scholar
Safety and efficacy of docetaxel + b-701, a selective inhibitor of FGFR3, in subjects with advanced or metastatic urothelial carcinoma.
J. Bellmunt, S. Pal, J. Picus, M. Kohli +5 more
201711 citations
Semantic Scholar
Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m)
R. García-Carbonero, E. Van Cutsem, F. Ciardiello, M. Ychou +10 more
201611 citations Open access
Semantic Scholar
253 Phase 1 correlative study of ARQ761, a β-lapachone analogue that promotes NQ01-mediated programmed cancer cell necrosis
D. Gerber, Y. Arriaga, M. Beg, J. Dowell +15 more
201410 citations
Semantic Scholar
A Narrative Review of Emerging Therapeutics for COVID-19
V. Willis, Y. Arriaga, D. Weeraratne, F. Reyes +1 more
2020Mayo Clinic Proceedings: Innovations, Quality & Outcomes9 citations Open access
Semantic Scholar
A phase I/Ib, multi-center trial of ARQ-761 (Beta-Lapachone) with gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer
M. Beg, D. Boothman, L. Khosama, Y. Arriaga +10 more
2019Annals of Oncology7 citations Open access
Semantic Scholar
A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma
J. Meyer, Y. Arriaga, Joselin L. Anandam, S. Karri +7 more
2017American Journal of Clinical Oncology7 citations
Semantic Scholar
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
H. Gogas, S. Ravimohan, Antara Datta, A. Chhibber +17 more
2024npj Precision Oncology6 citations Open access
Semantic Scholar
Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition
M. Dietrich, D. Cavuoti, M. Landay, Y. Arriaga
2014Journal of Investigative Medicine High Impact Case Reports5 citations Open access
Semantic Scholar
Shared-decision making in prostate cancer with clinical decision-support.
H. L. Rocha, I. Dankwa-Mullan, S. F. Juaçaba, V. Willis +3 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Metastatic Giant Condyloma Acuminata (Buschke-Löwenstein Tumor).
I. Bowman, A. Parra, Y. Arriaga
2016Journal of Oncology Practice4 citations
Semantic Scholar
Evaluating health disparities in access to genomic testing for metastatic non-small cell lung cancer patients.
Brian Yoon, D. Weeraratne, Y. Arriaga, Hu T. Huang +1 more
2021Journal of Clinical Oncology3 citations
Semantic Scholar
A phase II study of bavituximab and sorafenib in advanced hepatocellular carcinoma (HCC).
A. Yopp, A. Singal, Y. Arriaga, U. Verma +5 more
20153 citations
Semantic Scholar
1021 PROSPECTIVE VALIDATION OF MULTIPLE BIOMARKERS FOR IMPROVED CLINICAL DECISION-MAKING IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER
R. Youssef, S. Shariat, F. Alhalabi, C. Bolenz +5 more
20103 citations
Semantic Scholar
1473 Mechanism of action of bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) in patients with unresectable or metastatic melanoma from the phase 3 randomized open-label PIVOT IO-001 clinical trial
C. Lebbé, S. Ravimohan, A. Datta, A. Chhibber +13 more
2022Late-Breaking Abstracts2 citations Open access
Semantic Scholar
Abstract P4-14-05: A systematic review of concordance studies using Watson for Oncology (WfO) to support breast cancer treatment decisions: A four-year global experience
Y. Arriaga, Rezzan Hekmat, Karlis Draulis, Suwei Wang +4 more
20202 citations
Semantic Scholar
Early-onset colorectal cancer in younger patients: A population-based study.
Hu T. Huang, Suwei Wang, Elisabeth L. Scheufele, I. Dankwa-Mullan +2 more
20202 citations
Semantic Scholar
Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?
J. Stern, Y. Arriaga, Arjun Gupta, U. Verma +7 more
2019Pancreas2 citations
Semantic Scholar
Phase 1 study of ARQ 761, a β-lapachone analog that promotes NQO1-mediated programmed cancer cell necrosis.
D. Gerber, Ajit Bisen, M. Beg, A. Frankel +12 more
20172 citations
Semantic Scholar
PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)
E. Van Cutsem, F. Ciardiello, M. Ychou, J. Seitz +9 more
20162 citations Open access
Semantic Scholar
Regorafenib for previously treated metastatic colorectal cancer (mCRC): A subgroup analysis of 364 patients in the USA treated in the international, open-label phase IIIb CONSIGN study.
U. Verma, Y. Arriaga, H. Lenz, C. Henderson +13 more
20162 citations
Semantic Scholar
A Case Report on the Effect of Everolimus in Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Huma M Paika, Y. Arriaga, A. Setiawan
20142 citations
Semantic Scholar
A Targeted Review of Breast Cancer Studies of Concordance for an Internationally-Implemented Artificially Intelligent Clinical Decision-Support System
Y. Arriaga, Rezzan Hekmat, Karlis Draulis, Suwei Wang +7 more
20201 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Verma×9
Invite
U. Verma — researcher profile on SciRah
M. Beg×9
Invite
M. Beg — researcher profile on SciRah
I. Dankwa-Mullan×8
Invite
I. Dankwa-Mullan — researcher profile on SciRah
K. Courtney×7
Invite
K. Courtney — researcher profile on SciRah

×7

Invite

G. Jackson — researcher profile on SciRah

Invite

Y. Lotan — researcher profile on SciRah

A. Sagalowsky×7

Invite

A. Sagalowsky — researcher profile on SciRah

Invite

V. Willis — researcher profile on SciRah

Invite

V. Margulis — researcher profile on SciRah

J. Brugarolas×5

Invite

J. Brugarolas — researcher profile on SciRah

E. Van Cutsem×5

Invite

E. Van Cutsem — researcher profile on SciRah

Invite

A. Grothey — researcher profile on SciRah